PureTech Founded Entity Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx ® for Pediatric ADHD Patients in Japan
Japanese Product Now Under Review for Nationwide Marketing Approval Contacts PureTech Public Relations publicrelations@puretechhealth.com Investor Relations IR@puretechhealth.com EU Media Ben...